[서울와이어 박성필 기자] As news that Janssen, a global pharmaceutical company, a subsidiary of Johnson & Johnson, will release the third new coronavirus infection (Corona 19) vaccine next month after Pfizer and Modena, domestic related stocks are drawing attention.
Reuters reported that Janssen’s COVID-19 vaccine, which is being developed, is expected to be approved in January next year, citing a senior US health official. According to Reuters, Vice Minister of Health and Welfare Brett Girore appeared on ABC’s magazine program’Disweek’ on the 20th (local time) and announced that Janssen’s vaccine candidate would request approval for emergency use in January next year.
In the market, Janssen has not yet released data on the Corona 19 vaccine, but it is expected that a third commercialization will be possible. Janssen is conducting phase 3 clinical trials on about 45,000 people. It was temporarily stopped due to side effects during the previous clinical trial, but it resumed last month.
The Korean government plans to complete the contract with Janssen within this year with plans to receive vaccines for 4 million people. Accordingly, attention is focused on the stock prices of Yuhan Corporation, T&R Biofab, and Incon, which are domestic stocks related to Janssen.
First, Yuhan Corporation is considered a related stock as it established Janssen Korea through a joint venture with Johnson & Johnson. On the 21st, Yuhan Corporation’s stock price soared 8.58% from the previous trading day to close at 78,500 won. However, as of 10:30 am on the 22nd, Yuhan Corporation was trading at 76,200 won, down -2.93% from the previous day.
T&R Biofab is mentioned as a related state because it has a history of joint research and development of 3D bioprinting technology with Johnson & Johnson Medical. On the 21st, the stock price of T&R Biofab ended at 1,6950 won, down 2.87% from the previous trading day. Incondo’s subsidiary Xyber has recruited Vice Chairman Johnson & Johnson as chairman of the board of directors and is mentioned as a related item. Incon’s stock price on this day closed at 3995 won, down 1.36% from the previous trading day.
Meanwhile, T&R Biofab and Incon’s stock price as of 10:30 am on the 22nd is on the rise compared to the previous day’s closing price. At this time, T&R Biofab traded at 17,050 won, up 0.59% from the previous day. At the same time, Incondo recorded 4105 won, up 2.75% from the previous day.